The Exone Company (NASDAQ: XONE) reported Q1 EPS of ($0.20), $0.09 worse than the analyst estimate of ($0.11). Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE